InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Dahan Michel, 首席执行官. Insider active across 1 company, notably Akebia Therapeutics, Inc.. Aggregated, 9 disclosures have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €95k. Activity tracked since 28 February 2022. The latest transaction was disclosed on 13 May 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Dahan Michel is Directeur Général. Across 9 filings in total, the 9 sampled filings, all sales, concern Akebia Therapeutics, Inc., with total sales of EUR 95438 between 2022-03-02 and 2024-05-14.